FOXM1 and breast cancer: While miR‐802‐5p was shown to decrease  the proliferation of BCCs, through the downregulation of FoxM1 (Yuan and Wang, 2015), miR‐194‐5p has also been described to inhibit the proliferation and migration of BC, both in vivo and in vitro, though no specific targets were proposed (Le et al., 2012).